1. Home
  2. ETON vs BWAY Comparison

ETON vs BWAY Comparison

Compare ETON & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$30.66

Market Cap

689.8M

Sector

Health Care

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.39

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
BWAY
Founded
2017
2003
Country
United States
Israel
Employees
N/A
129
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
689.8M
674.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
BWAY
Price
$30.66
$16.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$39.33
$13.25
AVG Volume (30 Days)
346.1K
130.9K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$79,950,000.00
N/A
Revenue This Year
$40.90
$309.69
Revenue Next Year
$47.23
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
104.94
N/A
52 Week Low
$13.09
$8.63
52 Week High
$31.12
$26.63

Technical Indicators

Market Signals
Indicator
ETON
BWAY
Relative Strength Index (RSI) 73.46 57.32
Support Level $15.79 $14.56
Resistance Level N/A $16.63
Average True Range (ATR) 1.48 0.58
MACD 0.45 0.18
Stochastic Oscillator 82.26 74.18

Price Performance

Historical Comparison
ETON
BWAY

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: